Novartis AG, one of the world’s biggest of the Big Pharma companies, said in 2010 that it planned to begin embedding microchips in its medications as a means of creating “smart pills.”

The technology was licensed from Proteus Biomedical of Redwood City, Calif., and is activated by stomach acid. After activation the embedded chip begins sensing its environment and then broadcasts data to a receiver that the patient wears. The receiver is also a transmitter that can then send data via the Internet to the patient’s physician.

Source – http://newstarget.com/2016-05-23-big-pharma-set-to-start-microchipping-drugs.html